Comment: A European perspective on ADHD
Nikos Myttas
I am pleased to welcome our new European readers to ADHD in practice. From now on, the journal will devote space in each issue to look at attention deficit hyperactivity disorder (ADHD) from a European perspective – reviewing how it is regarded, diagnosed, managed and treated in different countries. In this issue, we begin to address the legal framework of prescribing medications for adult ADHD.
ADHD in practice 2010; 2(1): 3–3
To continue reading this article, please sign in or register.

ADHD in practice is supported by an unrestricted educational grant from MEDICE, with no editorial input into the content of this publication.

ADHD Together logo

ADHD in practice was previously supported by Shire from 2009 to 2016.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly, the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title ADHD in practice is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2019 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: editor@adhdinpractice.co.uk

ISSN 2041-2215 (Print) ISSN 2045-7766 (Online)